Superior vena cava occlusion caused by Behçet disease  by Yu, Miao et al.
Superior vena cava occlusion caused by
Behçet disease
Miao Yu, MD,a Anbing Shi, MD,d Bi Jin, MD,a Xionggang Jiang, MD,b Huimin Liang, MD,c and
Chenxi Ouyang, MD, PhD,a,d Wuhan, China; and Palo Alto, Calif
This case report described a patient of Behçet disease (BD)-related vascular lesions that initially presented as occlusion of
superior vena cava (SVC) without any evidence of thrombosis. The patient was treated first by percutaneous transluminal
angioplasty and stent implantation, and he developed thrombosis in the stent and then received open bypass operation.
Pathologic examination of the SVC specimen and the postoperative manifestations revealed that the underlying cause of
his symptoms as BD. Afterward, methylprednisolone plus anticoagulant therapy was routinely given, which relieved the
symptoms of the patient. ( J Vasc Surg 2012;55:1488-91.)
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eBehçet disease (BD) is a heterogeneous, multisystem
inflammatory condition and is a vasculitis syndrome with a
wide array of clinical manifestations.1 The classical triad of
BD consists of recurrent oral and genital ulcerations as well
as uveitis. Other systemic changes include skin lesions,
arthritis, neurologic, pulmonary involvement, and muscu-
loskeletal manifestations.2 Supra vena cava (SVC) throm-
bosis is a rare but easily identified manifestation of BD,
whereas reports of complete occlusion of SVC without
evidence of thrombosis, has been scanty in the literature.3
The open surgery or endovascular procedure for the treat-
ment of BD-related SVC syndrome has been rarely re-
ported, with postoperative course being eventful in most
cases.
In this case report, we described a case of BD-related
SVC occlusion without evidence of thrombosis and with-
out any manifestations typical of BD.
CASE REPORT
A 36-year-old Chinese male presented with progressive facial
and cervical swelling for 3 months, together with varicose veins in
the chest wall, and was admitted into our hospital in 2010. The
patient reported no history of thrombosis or family history of
similar conditions. On admission, the patient did not have persis-
tent fever, and he failed to mention that he had had oral ulceration
and lower extremity ulcers with skin pigmentation and itching over
the past several years and intermittent lower limb pain in the knee
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1488ith an impaired vision for 1 year, which led to our failure to
nclude BD as a possible diagnosis.
Computed tomography angiography, magnetic resonance an-
iography, and digital subtraction angiography revealed an exten-
ive filling defect with thickened wall of the SVC from the left
nnominate vein down to the right atrium, and profuse amount of
ascular collateral circulation in the soft tissue within the left
houlder (Fig 1). The other routine clinical examinations, includ-
ng erythrocyte sedimentation rate yielded normal results.
We first performed the balloon angioplasty under DSA to
nlarge SVC and to see if the obstruction was of functional or
tructural nature. During the DSA, the guidewire passed
hrough the narrow part of SVC without encountering any
esistance, and after the balloon enlargement, the facial swelling
isappeared immediately. However, the aforementioned symp-
oms recurred 1 week later and the patient’s general condition
eteriorated after treatment with anticoagulants and diuretics
o alleviate the edema. Thereafter, we performed an endovascu-
ar stent implantation at the site of SVC, with warfarin pre-
cribed, which alleviated his symptoms for a short period of
ime.
Unfortunately, the patient developed cervical swelling of
imilar severity 2-1/2 months later, and was readmitted into our
epartment. The second chest CTA scan exhibited a 6.5-cm-
ong stent of high density in the SVC and, within it, a lumen of
.0 mm in diameter with no obvious filling of contrast agent,
hich was considered to be thrombosis. We prescribed antico-
gulants to treat the thrombosis, which was ineffective. There-
ore, a mediastinotomy with replacement of the involved SVC
as performed in our cardiac surgery operating room.
After the successful establishment of cardiopulmonary bypass,
he vessel wall was cut open and the wall of the SVC vein was found
o be thickened. The bare stent was filled with dark red thrombi
Fig 2). We excised part of the thickened vessel wall for biopsy,
emoved the stent, and then performed a bypass of the right
ugular vein, innominate vein, and right atrium by using a Y-shaped
acron graft (Datascope 20  10  10 cm).
The patient’s swelling disappeared soon after the surgery.
owever, 4 days after the mediastinotomy, the patient devel-
ped a persistent fever of 38°C and a small amount of pleural
ffusion. Laboratory tests mostly yielded normal results except
or the following findings: WBCs were 11.27  109/L, protein
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Volume 55, Number 5 Yu et al 1489C was 55.3%, FVIII: C% was 153.9, and HLA-B51 test was
positive.
Histologic investigation showed irregular fibrous hyperpla-
sia of the SVC vessel wall, and a large number of small inflam-
matory vessels scattering among the hyperplasic tissues (Fig 3).
Especially, during the postoperative recovery period, the patient
began to complain of blurred vision and severe knee pain. These
manifestations, strongly indicative of BD, led us to consider BD
to be the cause of his symptoms. Methylprednisolone and
anticoagulants were administered, which successfully controlled
the fever that had lasted 2 weeks. Complete clinical resolution
was achieved 7 days after the treatment.
The patient was discharged and was ordered to take pred-
nisone (60 mg/d, with progressive dose reduction) and warfa-
rin. A 1-year follow-up showed that the patient did not have any
signs of recurrence of the cervical swelling, and ultrasound
Fig 1. The angiographic images of superior vena cava (S
resonance imaging (MRA), and digital subtraction angiogra
Fig 2. View of the stent and thrombi during the bypass o
B, Thrombi formed inside SVC.investigation showed no sign of thrombosis among the upper Timb veins. Moreover, his vision blurriness did not deteriorate
nd the arthralgia was relieved.
ISCUSSION
BD syndrome was first described in 1937 by Hulusi
ehçet, a Turkish dermatologist.4 Although vascular
esions are not included in the criteria for the diagnosis of
D, a significant proportion of the patients, ranging
rom 7% to 38%, develop complications in arterial and
enous vessels, which tend to cause deaths.5 The most
requent vascular lesions are superficial thrombophlebitis
nd venous occlusion of the upper limbs, followed by
cclusion of large vessels such as the superior and inferior
ena cava, aneurysm, or arterial occlusion.5,6 In addi-
ion, in 2006, Tohmé et al reported 18 cases, among 140
D patients, of vascular lesions at different parts of body.
y computed tomography angiography (CTA), magnetic
DSA). A, The obvious stenosis of SVC with thickened wall.
ion. A, The implanted stent in superior vena cava (SVC).VC) bperathey concluded that venous thrombosis was more com-
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May 20121490 Yu et almon in males, while arterial occlusion occurred more
frequently in females. In addition, arterial occlusions
were more commonly observed than aneurysms and
pulmonary embolism.7
To date, the mechanism of vascular lesions remains
unknown and there are no specific laboratory tests for the
Fig 3. The pathologic findings of the resected superior vena cava
(SVC). A, Profuse amount of newly formed vessels. B, Irregularly
distributed fibrinogen and fibroblasts.definite diagnosis of BD. It is commonly believed thatomplicated interactions among T cells, neutrophils, and
ntigen-presenting cells (APC) are implicated in the
mmunity-related pathogenesis of BD.8 Genetic abnormal-
ties are generally accepted risk factors for BD. In this case,
he patient’s parents were later found to be cousins. A
ecent study also suggested that major histocompatibility
omplex class I chain-related gene A, located near B51,
ight be the genetic locus for the condition in the Japanese
opulation.9
Second, we strongly suggest that separate diagnostic
riteria be established for BD with vascular involvement.
urrently, the main diagnostic criteria for BD are the
nternational Study Group (ISG) criteria, which were for-
ulated on the basis of the clinical features of the disease.
n this case, oral ulceration was not conspicuous and genital
lceration was totally absent. In 2008, Vandergheynst also
eported a patient presenting signs completely different
rom those included in ISG diagnostic criteria of BD.10
ince a significant proportion of the patients develop com-
lications in arterial and venous vessels,5 vascular lesions
hould be included in the diagnostic criteria of BD.
As an autoimmune disease, BD could involve virtually
ll systems in the body and are subject to relapse. In this
ase and with other patients reported in the literature, BD
ymptoms tend to worsen after invasive treatment for the
ascular lesions. Open surgery is associated with higher rate
f failure with the condition, resulting in graft occlusion,
tenosis, and pseudoaneurysm.11 The vasculitis-related vas-
ular change is principally ascribed to the high morbidity
nd disruption of suture lines at the early stage or pseudo-
neurysm at late stage, especially when the surgery is per-
ormed during the acute phase of the disease with inflam-
ation as indicated by high erythrocyte sedimentation rate
nd C-reactive protein level.1 Moreover, the stressful im-
act caused by open surgery also stimulates the immune
nd coagulation systems, which will accelerate the progres-
ion of BD. In this case, the persistent fever and vision
lurriness took place immediately after open operation, and
hrombotic complications developed after endovascular
tenting, which was consistent with the findings of other
tudies.12 Therefore, a standard treatment for BD with
ascular involvement should also be established.
ONCLUSIONS
On the basis of this case and review of the literature, we
onclude that any invasive treatment for BD-related vascu-
ar lesions should be avoided before the complete control of
ctive inflammation. Nevertheless, in the treatment of BD
ith involvement of large vessels, administration of immu-
osuppressors in conjunction of anticoagulants could
chieve satisfactory results in some cases.3,13
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